Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Nolde

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Clinical Oral Investigations|December 29, 2023
Targeted proteomics in a population-based study identifies serum PECAM-1 and TRIM21 as inflammation markers for periodontitisStefan Lars Reckelkamm, Inga Kamińska, Sebastian-Edgar Baumeister, et al.
Journal of Clinical Periodontology|May 15, 2022
Association between bone turnover markers and periodontitis: A population-based cross-sectional studyStefan Lars Reckelkamm, Anke Hannemann, Thomas Kocher, et al.
European Journal of Clinical Pharmacology|December 8, 2021
Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010-2018Ina-Maria Rückert-Eheberg, Michael Nolde, Nayeon Ahn, et al.
British Journal of Clinical Pharmacology|November 4, 2022
Do proton pump inhibitors increase the risk of dementia? A systematic review, meta-analysis and bias analysisNayeon Ahn, Michael Nolde, Evamaria Krause, et al.
European Journal of Neurology|February 16, 2022
Emulating a target trial of proton pump inhibitors and dementia risk using claims dataNayeon Ahn, Michael Nolde, Alexander Günter, et al.
Drugs & Aging|May 13, 2023
Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from GermanyNayeon Ahn, Nina Wawro, Sebastian-Edgar Baumeister, et al.
Alimentary Pharmacology & Therapeutics|September 3, 2021
The long-term risk for myocardial infarction or stroke after proton pump inhibitor therapy (2008-2018)Michael Nolde, Nayeon Ahn, Tobias Dreischulte, et al.
European Journal of Internal Medicine|October 4, 2022
Proton pump inhibitors and the risk of cardiovascular events and cardiovascular mortality: A systematic review and meta-analysis of observational studiesMichael Nolde, Nayeon Ahn, Tobias Dreischulte, et al.
Pharmacotherapy|January 19, 2021
Association of proton pump inhibitor use with endothelial function and metabolites of the nitric oxide pathway: A cross-sectional studyMichael Nolde, Martin Bahls, Nele Friedrich, et al.
European Journal of Clinical Pharmacology|January 14, 2021
Lack of association between proton pump inhibitor use and brain aging: a cross-sectional studyNayeon Ahn, Stefan Frenzel, Katharina Wittfeld, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Clinical Oral Investigations|December 29, 2023
Targeted proteomics in a population-based study identifies serum PECAM-1 and TRIM21 as inflammation markers for periodontitisStefan Lars Reckelkamm, Inga Kamińska, Sebastian-Edgar Baumeister, et al.
Journal of Clinical Periodontology|May 15, 2022
Association between bone turnover markers and periodontitis: A population-based cross-sectional studyStefan Lars Reckelkamm, Anke Hannemann, Thomas Kocher, et al.
European Journal of Clinical Pharmacology|December 8, 2021
Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010-2018Ina-Maria Rückert-Eheberg, Michael Nolde, Nayeon Ahn, et al.
British Journal of Clinical Pharmacology|November 4, 2022
Do proton pump inhibitors increase the risk of dementia? A systematic review, meta-analysis and bias analysisNayeon Ahn, Michael Nolde, Evamaria Krause, et al.
European Journal of Neurology|February 16, 2022
Emulating a target trial of proton pump inhibitors and dementia risk using claims dataNayeon Ahn, Michael Nolde, Alexander Günter, et al.
Drugs & Aging|May 13, 2023
Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from GermanyNayeon Ahn, Nina Wawro, Sebastian-Edgar Baumeister, et al.
Alimentary Pharmacology & Therapeutics|September 3, 2021
The long-term risk for myocardial infarction or stroke after proton pump inhibitor therapy (2008-2018)Michael Nolde, Nayeon Ahn, Tobias Dreischulte, et al.
European Journal of Internal Medicine|October 4, 2022
Proton pump inhibitors and the risk of cardiovascular events and cardiovascular mortality: A systematic review and meta-analysis of observational studiesMichael Nolde, Nayeon Ahn, Tobias Dreischulte, et al.
Pharmacotherapy|January 19, 2021
Association of proton pump inhibitor use with endothelial function and metabolites of the nitric oxide pathway: A cross-sectional studyMichael Nolde, Martin Bahls, Nele Friedrich, et al.
European Journal of Clinical Pharmacology|January 14, 2021
Lack of association between proton pump inhibitor use and brain aging: a cross-sectional studyNayeon Ahn, Stefan Frenzel, Katharina Wittfeld, et al.
Pageof 4